TY - JOUR
T1 - Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TPF-beta Signaling and Epigenomics
T2 - Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics
AU - Piché, Jessica
AU - Gosset, Natacha
AU - Legault, Lisa-Marie
AU - Pacis, Alain
AU - Oneglia, Andrea
AU - Caron, Maxime
AU - Chetaille, Philippe
AU - Barreiro, Luis
AU - Liu, Donghai
AU - Qi, Xioyan
AU - Nattel, Stanley
AU - Leclerc, Séverine
AU - Breton-Larrivée, Mélanie
AU - McGraw, Serge
AU - Andelfinger, Gregor
AU - Bakkers, Jeroen
N1 - Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - BACKGROUND & AIMS: A generalized human pacemaking syndrome, chronic atrial and intestinal dysrhythmia (CAID) (OMIM 616201), is caused by a homozygous SGO1 mutation (K23E), leading to chronic intestinal pseudo-obstruction and arrhythmias. Because CAID patients do not show phenotypes consistent with perturbation of known roles of SGO1, we hypothesized that noncanonical roles of SGO1 drive the clinical manifestations observed.METHODS: To identify a molecular signature for CAID syndrome, we achieved unbiased screens in cell lines and gut tissues from CAID patients vs wild-type controls. We performed RNA sequencing along with stable isotope labeling with amino acids in cell culture. In addition, we determined the genome-wide DNA methylation and chromatin accessibility signatures using reduced representative bisulfite sequencing and assay for transposase-accessible chromatin with high-throughput sequencing. Functional studies included patch-clamp, quantitation of transforming growth factor-β (TGF-β) signaling, and immunohistochemistry in CAID patient gut biopsy specimens.RESULTS: Proteome and transcriptome studies converge on cell-cycle regulation, cardiac conduction, and smooth muscle regulation as drivers of CAID syndrome. Specifically, the inward rectifier current, an important regulator of cellular function, was disrupted. Immunohistochemistry confirmed overexpression of Budding Uninhibited By Benzimidazoles 1 (BUB1) in patients, implicating the TGF-β pathway in CAID pathogenesis. Canonical TGF-β signaling was up-regulated and uncoupled from noncanonical signaling in CAID patients. Reduced representative bisulfite sequencing and assay for transposase-accessible chromatin with high-throughput sequencing experiments showed significant changes of chromatin states in CAID, pointing to epigenetic regulation as a possible pathologic mechanism.CONCLUSIONS: Our findings point to impaired inward rectifier potassium current, dysregulation of canonical TGF-β signaling, and epigenetic regulation as potential drivers of intestinal and cardiac manifestations of CAID syndrome. Transcript profiling and genomics data are as follows: repository URL: https://www.ncbi.nlm.nih.gov/geo; SuperSeries GSE110612 was composed of the following subseries: GSE110309, GSE110576, and GSE110601.
AB - BACKGROUND & AIMS: A generalized human pacemaking syndrome, chronic atrial and intestinal dysrhythmia (CAID) (OMIM 616201), is caused by a homozygous SGO1 mutation (K23E), leading to chronic intestinal pseudo-obstruction and arrhythmias. Because CAID patients do not show phenotypes consistent with perturbation of known roles of SGO1, we hypothesized that noncanonical roles of SGO1 drive the clinical manifestations observed.METHODS: To identify a molecular signature for CAID syndrome, we achieved unbiased screens in cell lines and gut tissues from CAID patients vs wild-type controls. We performed RNA sequencing along with stable isotope labeling with amino acids in cell culture. In addition, we determined the genome-wide DNA methylation and chromatin accessibility signatures using reduced representative bisulfite sequencing and assay for transposase-accessible chromatin with high-throughput sequencing. Functional studies included patch-clamp, quantitation of transforming growth factor-β (TGF-β) signaling, and immunohistochemistry in CAID patient gut biopsy specimens.RESULTS: Proteome and transcriptome studies converge on cell-cycle regulation, cardiac conduction, and smooth muscle regulation as drivers of CAID syndrome. Specifically, the inward rectifier current, an important regulator of cellular function, was disrupted. Immunohistochemistry confirmed overexpression of Budding Uninhibited By Benzimidazoles 1 (BUB1) in patients, implicating the TGF-β pathway in CAID pathogenesis. Canonical TGF-β signaling was up-regulated and uncoupled from noncanonical signaling in CAID patients. Reduced representative bisulfite sequencing and assay for transposase-accessible chromatin with high-throughput sequencing experiments showed significant changes of chromatin states in CAID, pointing to epigenetic regulation as a possible pathologic mechanism.CONCLUSIONS: Our findings point to impaired inward rectifier potassium current, dysregulation of canonical TGF-β signaling, and epigenetic regulation as potential drivers of intestinal and cardiac manifestations of CAID syndrome. Transcript profiling and genomics data are as follows: repository URL: https://www.ncbi.nlm.nih.gov/geo; SuperSeries GSE110612 was composed of the following subseries: GSE110309, GSE110576, and GSE110601.
KW - Abnormalities, Multiple/genetics
KW - Adult
KW - Cell Cycle Proteins/metabolism
KW - DNA Methylation/genetics
KW - Dermis/pathology
KW - Epigenomics
KW - Fibroblasts/metabolism
KW - Gene Expression Profiling
KW - Gene Ontology
KW - Humans
KW - Potassium Channels/metabolism
KW - Proteome/metabolism
KW - Reproducibility of Results
KW - Signal Transduction
KW - Syndrome
KW - Transforming Growth Factor beta/metabolism
KW - Chronic Intestinal Pseudo-obstruction
KW - TGF-β Signaling
KW - CAID Syndrome (Chronic Atrial and Intestinal Dysrhythmia)
KW - Epigenetics
KW - TGF-beta Signaling
UR - http://www.scopus.com/inward/record.url?scp=85061108051&partnerID=8YFLogxK
U2 - 10.1016/j.jcmgh.2018.10.011
DO - 10.1016/j.jcmgh.2018.10.011
M3 - Article
C2 - 30739867
SN - 2352-345X
VL - 7
SP - 411
EP - 431
JO - Cellular and molecular gastroenterology and hepatology
JF - Cellular and molecular gastroenterology and hepatology
IS - 2
ER -